Scientific Research Support Component C/Non- Human Primates
科学研究支持成分 C/非人类灵长类动物
基本信息
- 批准号:9089830
- 负责人:
- 金额:$ 108.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAffinityAnimal ModelAnimalsAntibodiesAntigensAutopsyBasic ScienceBlood specimenCD4 Positive T LymphocytesCellsComplexData AnalysesData CollectionDevelopmentEnsureGoalsHIV-1Helper-Inducer T-LymphocyteHuman ResourcesImmune responseImmunizationImmunologicsImmunologyInfectionIsraelLeadershipMacaca mulattaMedical centerMissionMonoclonal AntibodiesPositioning AttributePreclinical TestingPrimatesProceduresProtocols documentationQuality ControlReagentResearchResearch InfrastructureResearch PersonnelResearch SupportResourcesRoleSIVSamplingTechnical ExpertiseTestingTissue SampleUniversitiesVaccinesWalkersWorkanimal carehigh standardimmunogenicityin vivomeetingsnonhuman primatenovelprogramsprotective efficacyresearch studyresponsesimian human immunodeficiency virussuccessvirus characteristic
项目摘要
Infection of rhesus macaques with simian immunodeficiency virus (SIV) or simian-human immunodeficiency virus (SHIV) is a key animal model for HIV-1 infection. The Nonhuman Primate (NHP) Scientific Research Support Component (SRSC) aims to support this CHAVI-ID by providing all the expertise, infrastructure, reagents, personnel, and animals for the conduct of complex in vivo immunogenicity and challenge studies in NHPs. This SRSC will involve leadership from both Beth Israel Deaconess Medical Center and the Yerkes National Primate Research Center (Emory University) and is well positioned to meet the CHAVI-ID goals.
This SRSC leadership will work closely with the research discovery teams responsible for the studies described in Scientific Foci #1 and#2 and participate actively in the scientific mission of this CHAVI-ID. The main role of this SRSC is to provide leadership and technical expertise to ensure consistency and quality control in animal selection, execution of study protocols, experimental procedures, sample acquisition and distribution, immunologic and virologic studies, and data collection and analysis. The Specific Aims are:
1. To support this CHAVI-ID by selecting and providing rhesus macaques, providing exceptional animal care, conducting experimental studies with monoclonal antibodies (MAbs) and vaccines, collecting samples for immunologic and virologic testing, and performing necropsy studies. These studies will initially evaluate:
A. Protective efficacy of HIV-1 Env-specific MAbs against SHIV challenge;
B. Immunogenicity and protective efficacy of novel HIV-1 Env immunogens and immunization strategies;
2. To support this CHAVI-ID by providing blood and tissue samples from SIV/SHIV-infected and uninfected NHPs to collaborating investigators to underpin basic research studies. These samples will support studies of neutralizing Abs in Focus #1 and will help elucidate the characteristics of virus-specific CD4+ follicular helper T cell (Tfh) responses in Focus #2, with an initial emphasis on the development of Tfh cells during vaccine-induced immune responses and the role of Tfh cells in promoting the affinity maturation of antibodies.
猴免疫缺陷病毒(SIV)或猴-人免疫缺陷病毒(SHIV)感染恒河猴是HIV-1感染的关键动物模型。非人灵长类动物(NHP)科学研究支持组件(SRSC)旨在通过提供所有专业知识、基础设施、试剂、人员和动物来支持该CHAVI-ID,以便在NHP中进行复杂的体内免疫原性和挑战研究。该SRSC将涉及来自Beth Israel Deaconess Medical Center和Yerkes National Primate Research Center(Emory University)的领导,并有能力实现CHAVI-ID的目标。
该SRSC领导层将与负责科学焦点#1和#2中所述研究的研究发现团队密切合作,并积极参与CHAVI-ID的科学使命。该SRSC的主要作用是提供领导和技术专业知识,以确保动物选择、研究方案执行、实验程序、样本采集和分发的一致性和质量控制,免疫学和病毒学研究以及数据收集和分析。具体目标是:
1.通过选择和提供恒河猴、提供特殊的动物护理、使用单克隆抗体(MAb)和疫苗进行实验研究、采集用于免疫学和病毒学检测的样本以及进行尸检研究,支持CHAVI-ID。这些研究将首先评估:
A. HIV-1 Env特异性单克隆抗体对SHIV攻击的保护作用
B。新型HIV-1 Env免疫原的免疫原性、保护效果及免疫策略
2.通过向合作研究者提供SIV/SHIV感染和未感染NHP的血液和组织样本来支持CHAVI-ID,以支持基础研究。这些样本将支持焦点#1中中和抗体的研究,并将有助于阐明焦点#2中病毒特异性CD 4+滤泡辅助T细胞(Tfh)应答的特征,最初重点是疫苗诱导免疫应答期间Tfh细胞的发育以及Tfh细胞在促进抗体亲和力成熟中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dan H. Barouch其他文献
Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV
- DOI:
10.1186/s12865-025-00687-7 - 发表时间:
2025-02-19 - 期刊:
- 影响因子:2.700
- 作者:
Tariro D. Chawana;Stephen R. Walsh;Lynda Stranix-Chibanda;Zvavahera M. Chirenje;Chenchen Yu;Lily Zhang;Kelly E. Seaton;Jack Heptinstall;Lu Zhang;Carmen A. Paez;Theresa Gamble;Shelly T. Karuna;Philip Andrew;Brett Hanscom;Magdalena E. Sobieszczyk;Srilatha Edupuganti;Cynthia L. Gay;Sharon B. Mannheimer;Christopher B. Hurt;Kathryn E. Stephenson;Laura L. Polakowski;Hans Spiegel;Margaret Yacovone;Stephanie Regenold;Catherine Yen;Jane AG. Baumblatt;Lucio Gama;Dan H. Barouch;Estelle Piwowar-Manning;Richard A. Koup;Georgia D. Tomaras;Ollivier Hyrien;Alison C. Roxby;Yunda Huang - 通讯作者:
Yunda Huang
On-patient medical record and mRNA therapeutics using intradermal microneedles
住院病历与使用皮内微针的信使核糖核酸疗法
- DOI:
10.1038/s41563-024-02115-4 - 发表时间:
2025-02-24 - 期刊:
- 影响因子:38.500
- 作者:
Jooli Han;Maria Kanelli;Yang Liu;John L. Daristotle;Apurva Pardeshi;Timothy A. Forster;Ari Karchin;Brandon Folk;Lukas Murmann;Lisa H. Tostanoski;Sebastian E. Carrasco;Shahad K. Alsaiari;Erika Yan Wang;Khanh Tran;Linzixuan Zhang;Behnaz Eshaghi;Lauren Levy;Sydney Pyon;Charles Sloane;Stacey Qiaohui Lin;Alicia Lau;Collin F. Perkinson;Moungi G. Bawendi;Dan H. Barouch;Frédo Durand;Robert Langer;Ana Jaklenec - 通讯作者:
Ana Jaklenec
Attenuated emMycobacterium tuberculosis/em vaccine protection in a low-dose murine challenge model
减毒鼠伤寒沙门菌疫苗在低剂量小鼠攻击模型中的保护作用
- DOI:
10.1016/j.isci.2023.106963 - 发表时间:
2023-06-16 - 期刊:
- 影响因子:4.100
- 作者:
Samuel J. Vidal;Daniel Sellers;Jingyou Yu;Shoko Wakabayashi;Jaimie Sixsmith;Malika Aid;Julia Barrett;Sage F. Stevens;Xiaowen Liu;Wenjun Li;Courtney R. Plumlee;Kevin B. Urdahl;Amanda J. Martinot;Dan H. Barouch - 通讯作者:
Dan H. Barouch
SIV proviruses seeded later in infection are harbored in short-lived CD4sup+/sup T cells
在感染后期植入的猴免疫缺陷病毒(SIV)前病毒存在于短寿命的CD4<sup>+</sup>T细胞中
- DOI:
10.1016/j.celrep.2025.115663 - 发表时间:
2025-05-27 - 期刊:
- 影响因子:6.900
- 作者:
Narmada Sambaturu;Emily J. Fray;Vivek Hariharan;Fengting Wu;Carolin Zitzmann;Francesco R. Simonetti;Dan H. Barouch;Janet D. Siliciano;Robert F. Siliciano;Ruy M. Ribeiro;Alan S. Perelson;Carmen Molina-París;Thomas Leitner - 通讯作者:
Thomas Leitner
Nonhuman primate antigenic cartography of SARS-CoV-2
非人类灵长类动物对 SARS-CoV-2 的抗原图谱
- DOI:
10.1016/j.celrep.2024.115140 - 发表时间:
2025-01-28 - 期刊:
- 影响因子:6.900
- 作者:
Annika Rössler;Antonia Netzl;Ninaad Lasrado;Jayeshbhai Chaudhari;Barbara Mühlemann;Samuel H. Wilks;Janine Kimpel;Derek J. Smith;Dan H. Barouch - 通讯作者:
Dan H. Barouch
Dan H. Barouch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dan H. Barouch', 18)}}的其他基金
Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination
广泛中和抗体和治疗性疫苗的多组学分析
- 批准号:
10724219 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
Multi-Omics Correlates of Broadly Neutralizing Antibody Efficacy
广泛中和抗体功效的多组学关联
- 批准号:
10724224 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
CoVPN LOC Cross-Protocol Infrastructure Supplement for GY15 and GY16
适用于 GY15 和 GY16 的 CoVPN LOC 跨协议基础设施补充
- 批准号:
10571201 - 财政年份:2022
- 资助金额:
$ 108.13万 - 项目类别:
Project 2: Analysis of Reservoir Dynamics in SIV-Infected Rhesus Macaques
项目 2:感染 SIV 的恒河猴的储库动力学分析
- 批准号:
10599365 - 财政年份:2022
- 资助金额:
$ 108.13万 - 项目类别:
Project 2: Analysis of Reservoir Dynamics in SIV-Infected Rhesus Macaques
项目 2:感染 SIV 的恒河猴的储库动力学分析
- 批准号:
10459662 - 财政年份:2022
- 资助金额:
$ 108.13万 - 项目类别:
HIV Vaccines Clinical Trials Network Leadership and Operations Center
HIV 疫苗临床试验网络领导和运营中心
- 批准号:
10311601 - 财政年份:2021
- 资助金额:
$ 108.13万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 108.13万 - 项目类别:
Continuing Grant